Graham Capital Management »

Trevi Therapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $449k 49k 9.15
2025-06-30 $219k 40k 5.47

More positions owned by Graham Capital Management

Strategy Cl A New (MSTR)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Fidelity Wise Origin Bitcoin SHS Put Option (FBTC)
Eos Energy Enterprises Com Cl A Put Option (EOSE)
Purecycle Technologies Note 7.250% 8/1 (Principal)
Vaneck Etf Trust Gold Miners Etf (GDX)
Tilray Brands Note 5.200% 6/1 (Principal)
Sunrun Note 4.000% 3/0 (Principal)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Rivian Automotive Note 3.625%10/1 (Principal)

View all positions for Graham Capital Management

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Viking Global Investors
Vivo Capital
Marshall Wace
Alliancebernstein
MPM Oncology Impact Management
OrbiMed Advisors
FMR
Wellington Management Company
Octagon Capital Advisors
Affinity Asset Advisors

View all funds holding Trevi Therapeutics